Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00740909 · ClinicalTrials.gov registry record · Phase 1

Cognitive Behavioral Therapy for Trichotillomania

A Phase 1 study of Trichotillomania, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 1
Development phase
38
Enrollment target
1
Study location

NCT00740909: Completed Phase 1 study of Trichotillomania, sponsored by Massachusetts General Hospital.

NCT00740909 is a Phase 1 study of Trichotillomania that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants, below the 67-participant average among 8 other Trichotillomania trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00740909, a Phase 1 study of Trichotillomania, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 1
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid affective symptoms, as well. The study will compare the efficacy of CBT with a minimal attention control (MAC)condition. We hypothesize that outcome at post-treatment, 3-month, and 6-month follow-up will be better for the CBT vs. MAC condition including higher responder rates and greater reduction in hair pulling severity.

Conditions Studied

Trichotillomania

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2008-11
Est. Completion 2012-01
Phase Phase 1
Massachusetts General Hospital

2,032 total trials

What the finished NCT00740909 record still lists

NCT00740909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 67-participant average among 8 other Trichotillomania trials with a reported enrollment target (43% lower).

The record links to 1 condition, with Trichotillomania appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT00740909 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00740909 about?

NCT00740909 is a clinical study titled "Cognitive Behavioral Therapy for Trichotillomania". This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid affective symptoms, as well. The study will compare the efficacy of CBT with a minimal attention control (MAC)condi...

What is the current status of trial NCT00740909?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2008-11. Estimated completion is 2012-01.

What conditions does trial NCT00740909 study?

This clinical trial studies the following conditions: Trichotillomania.

What interventions are being tested in trial NCT00740909?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00740909?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00740909 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Trichotillomania

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00740909's enrollment target sits among peer trials

38 5th of 8 higher than 4 of 8 other Trichotillomania trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Trichotillomania trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00740909, the US trial registry maintained by the National Library of Medicine. NCT00740909 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.